尼日利亚女性遗传性乳腺癌的基因突变分析
该研究在尼日利亚伊巴丹纳入1136例浸润性乳腺癌患者和997名无癌对照,采用BROCA panel测序检测已知及候选乳腺癌基因的功能丧失突变。结果显示14.7%的患者携带乳腺癌基因的功能丧失突变,其中BRCA1占7.0%、BRCA2占4.1%、PALB2占1.0%、TP53占0.4%;BRCA1和BRCA2突变与乳腺癌风险显著相关,PALB2和TP53突变也显示显著关联。作者认为八分之一的浸润性乳腺癌由BRCA1、BRCA2、PALB2或TP53的遗传突变所致。
要点
- 尼日利亚乳腺癌患者中14.7%携带乳腺癌基因功能丧失突变,BRCA1占7.0%、BRCA2占4.1%。
- BRCA1突变者更年轻且更易患三阴性乳腺癌(P<.001和P=.028)。
- PALB2和TP53突变与乳腺癌风险显著关联(P=.002和P=.036)。
核心结论
- 尼日利亚女性浸润性乳腺癌中八分之一由BRCA1、BRCA2、PALB2或TP53的遗传突变所致,相关基因的乳腺癌风险极高。
- 鉴于资源有限,预防和早期检测服务应特别关注这些最高风险女性。
研究设计与样本
- 病例对照研究,纳入尼日利亚伊巴丹1136例浸润性乳腺癌患者(诊断时平均年龄47.5±11.5岁)和997名来自同一社区的无癌对照(访谈时平均年龄47.0±12.4岁)。
- 患者入选不考虑诊断年龄、家族史或既往基因检测情况。
- 采用BROCA panel测序鉴定已知和候选乳腺癌基因的功能丧失突变。
主要发现
- 577例有肿瘤分期信息的患者中,86.1%(497例)诊断时为III期(241例)或IV期(256例)。
- 290例有肿瘤激素受体和人表皮生长因子受体2信息的患者中,45.9%(133例)为三阴性乳腺癌。
- 全部病例中14.7%(1136例中167例)携带乳腺癌基因功能丧失突变:BRCA1占7.0%、BRCA2占4.1%、PALB2占1.0%、TP53占0.4%、其他10个基因中任一基因占2.1%。
- BRCA1的比值比为23.4(95%CI 7.4至73.9),BRCA2为10.3(95%CI 3.7至28.5)。
- PALB2(11例病例、零对照;P=.002)和TP53(5例病例、零对照;P=.036)的风险也显著相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Among Nigerian women, breast cancer is diagnosed at later stages, is more frequently triple-negative disease, and is far more frequently fatal than in Europe or the United States. We evaluated the contribution of an inherited predisposition to breast cancer in this population. PATIENTS AND METHODS: Cases were 1,136 women with invasive breast cancer (mean age at diagnosis, 47.5 ± 11.5 years) ascertained in Ibadan, Nigeria. Patients were selected regardless of age at diagnosis, family history, or prior genetic testing. Controls were 997 women without cancer (mean age at interview, 47.0 ± 12.4 years) from the same communities. BROCA panel sequencing was used to identify loss-of-function mutations in known and candidate breast cancer genes. RESULTS: Of 577 patients with information on tumor stage, 86.1% (497) were diagnosed at stage III (241) or IV (256). Of 290 patients with information on tumor hormone receptor status and human epidermal growth factor receptor 2, 45.9% (133) had triple-negative breast cancer. Among all cases, 14.7% (167 of 1,136) carried a loss-of-function mutation in a breast cancer gene: 7.0% in BRCA1, 4.1% in BRCA2, 1.0% in PALB2, 0.4% in TP53, and 2.1% in any of 10 other genes. Odds ratios were 23.4 (95% CI, 7.4 to 73.9) for BRCA1 and 10.3 (95% CI, 3.7 to 28.5) for BRCA2. Risks were also significantly associated with PALB2 (11 cases, zero controls; P = .002) and TP53 (five cases, zero controls; P = .036). Compared with other patients, BRCA1 mutation carriers were younger ( P < .001) and more likely to have triple-negative breast cancer ( P = .028). CONCLUSION: Among Nigerian women, one in eight cases of invasive breast cancer is a result of inherited mutations in BRCA1, BRCA2, PALB2, or TP53, and breast cancer risks associated with these genes are extremely high. Given limited resources, prevention and early detection services should be especially focused on these highest-risk women.
引用
- Zheng Y, Walsh T, Gulsuner S, et al. Inherited Breast Cancer in Nigerian Women. J Clin Oncol. 2018. PMID: 30130155. doi:10.1200/JCO.2018.78.3977
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。